Why Insulin Resistance Changes Where Your Body Stores Fat
Insulin resistance is often described as a blood-sugar problem. That description is incomplete.
The more accurate picture is this: insulin resistance and body-fat storage work in both directions. Excess or poorly stored fat makes the body less responsive to insulin. Higher insulin then pushes more fat into the abdomen, liver, and other places it does not belong. The scale may move slowly, or not at all, while the location of fat keeps changing the way the body handles energy.
Understanding that loop matters if you are trying to reduce midsection fat, improve energy, or train without feeling metabolically stuck.
Fat location matters more than total weight
Two people can carry a similar amount of body fat and have very different metabolic health. The difference is usually where the fat is stored and how healthy the fat cells themselves are.
Visceral fat — the fat around the organs in the abdomen — is the strongest predictor of insulin resistance. Gluteofemoral fat, stored around the hips and thighs, is often metabolically quieter. It releases fatty acids more slowly and is associated with better insulin sensitivity.
How fat tissue expands also matters:
- Hyperplasia adds new, smaller fat cells. Lipid is distributed across more cells, which tends to be better tolerated.
- Hypertrophy enlarges existing fat cells. Large cells become poorly oxygenated, inflamed, and less responsive to insulin.
When subcutaneous fat — the fat under the skin that is meant to store energy safely — can no longer expand in a healthy way, the surplus does not disappear. It overflows. Free fatty acids rise because insulin can no longer suppress fat breakdown as it should. Those fatty acids then settle in the liver, muscle, and pancreas. Researchers call this ectopic fat. The lipid byproducts that form there interfere with insulin signaling. That is one of the main reasons extra abdominal fat and insulin resistance travel together.
This also explains why some people develop insulin resistance at a relatively modest body weight, while others remain metabolically healthier at a higher weight. Each person appears to have a practical limit to how much fat can be stored safely under the skin. Once that limit is crossed, even a small additional surplus can raise liver fat and worsen insulin action.
Insulin is a storage hormone — and it does not shut off evenly
Insulin’s job after a meal is to move glucose into cells and to store surplus energy. In adipose tissue it:
- slows the breakdown of stored fat
- increases uptake of fatty acids
- supports the conversion of carbohydrate into new fat
- helps lock energy into triglycerides inside fat cells
That is normal physiology. The problem begins when tissues become selectively resistant.
In the liver, insulin often loses its ability to turn down glucose production while it continues to stimulate fat synthesis. The result can be higher blood sugar and more liver fat at the same time. In fat tissue, the brake on fat breakdown often weakens. Fatty acids leak into circulation even while remaining insulin action still favors storage in the depots that are still responsive — frequently the abdomen.
Human research has added an important detail. People who secrete unusually high amounts of insulin, even when whole-body insulin sensitivity looks similar to their peers, tend to have larger abdominal fat cells, more visceral fat, more liver fat, and greater fat gain over time. Insulin therapy in type 2 diabetes is also associated with weight gain. In other words, chronically elevated insulin is not only a response to fat gain. It can also promote further storage.
The cycle that keeps midsection fat in place
The two processes close a loop:
- Surplus energy and limited healthy storage capacity produce larger, inflamed fat cells and ectopic fat.
- Ectopic fat and inflammatory signals reduce insulin action in muscle and liver.
- The pancreas compensates by releasing more insulin.
- Higher insulin continues to favor fat synthesis and suppress fat use, especially in visceral and hepatic depots.
- Those depots then worsen insulin resistance.
This is why “eat less and move more” can feel incomplete. Energy balance still matters. The partitioning of that energy — whether it is stored under the skin, around the organs, or inside the liver — also matters. Two people can eat similar calories and end up with different metabolic results because their storage capacity, muscle quality, sleep, stress load, and insulin response are not the same.
What this means for training and daily habits
You cannot out-supplement a cycle that is being driven by excess energy, low muscle demand, and poor recovery. You can, however, change the inputs that determine where energy goes.
Build and use muscle. Skeletal muscle is the largest site of insulin-stimulated glucose uptake. Strength training improves that uptake even before large changes in body weight appear. For clients with pain or compensation patterns, the first step is not maximal loading. It is restoring the muscles that should be doing the work so training can be progressive rather than inflammatory.
Reduce visceral and liver fat, not only scale weight. Moderate, consistent energy restriction and resistance training both help. The clinically meaningful target is often a reduction in waist circumference and intra-abdominal fat, not a specific number on the scale. Clearing ectopic fat can improve insulin action relatively quickly.
Do not chase insulin in isolation. Very low-carbohydrate approaches can lower insulin in some people. They are not the only path, and they are not automatically superior to a well-constructed mixed diet that supports training, protein intake, and adherence. Chronically elevated basal insulin appears more relevant to fat gain than a normal rise in insulin after a mixed meal.
Treat sleep, alcohol, and inactivity as metabolic variables. Poor sleep and excess alcohol both favor abdominal storage and reduce insulin sensitivity. Sitting for long periods lowers muscle glucose uptake even in people who exercise later in the day.
Assess the person, not the diagnosis. Insulin resistance often shows up alongside low hip-extension strength, limited thoracic mobility, a rigid breathing pattern, and an inability to train hard enough to change body composition. Those mechanical issues are not separate from the metabolic picture. They determine whether a program is actually performed well enough to matter.
A practical way to think about it
Insulin resistance is not simply “too much sugar.” Body fat is not simply “too many calories.” The useful model is storage capacity versus overflow.
When subcutaneous fat can still expand in a healthy way, extra energy has a relatively safe place to go. When it cannot, the same surplus becomes visceral and ectopic fat, insulin action declines, and higher insulin makes further storage more likely. Training that restores muscle function, nutrition that supports a modest energy deficit without collapsing recovery, and habits that lower basal insulin exposure all work on different parts of the same loop.
If midsection fat, energy crashes, or stalled progress are part of what brought you in, the question is not only how much you weigh. It is how your body is currently storing and using fuel — and whether your muscle system is in a position to change that.
Stilwell Health & Fitness is a Muscle System Specialist practice in Arcata, serving Humboldt County. Work begins with an assessment of how your muscles are functioning, then a program built around pain, movement quality, strength, and the nutrition needed to support it.
Free 15-minute consult: (707) 798-0512 or visit stilwellhealthandfitness.com. 475 5th Street, Arcata, CA 95521.
Selected sources
- Mittendorfer B, Johnson JD. Insulin hypersecretion as promoter of body fat gain and hyperglycemia. Diabetes. 2024.
- Tricò D, et al. Alterations in adipose tissue distribution, cell morphology, and function mark primary insulin hypersecretion in youth with obesity. Diabetes. 2024.
- Klein S, Gastaldelli A, Yki-Järvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metabolism. 2022.
- Taylor R, Holman RR. Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clinical Science. 2015.
- Diabetology & Metabolic Syndrome. White adipose tissue expansion as the driver of insulin resistance (narrative review). 2026.